Fang Yuan Li

Title: Innovations of Fang Yuan Li in Photodynamic Therapy

Introduction

Fang Yuan Li is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of photodynamic diagnosis and therapy. His innovative work focuses on developing conjugates that enhance the effectiveness of cancer treatments.

Latest Patents

Fang Yuan Li holds a patent for a conjugate designed for photodynamic diagnosis or therapy. The patent, titled "Conjugate for photodynamic diagnosis or therapy and method for preparing same," describes a conjugate of acetylated biocompatible polysaccharide and a phthalocyanine-based compound. This invention aims to improve solubility in solvents, allowing for various chemical modifications. The conjugate specifically targets tumor cells, demonstrating superior cancer cell selection and accumulation. It effectively kills cancer cells when exposed to near-infrared radiation while showing no cytotoxicity to non-cancerous cells. This characteristic ensures its stability in vivo, making it a valuable tool for disease diagnosis and therapy using photodynamics.

Career Highlights

Fang Yuan Li is associated with Panaxem Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on cancer treatment methodologies.

Collaborations

Fang Yuan Li collaborates with notable colleagues, including Kun Na and Byoung Chan Bae, who contribute to his research endeavors.

Conclusion

Fang Yuan Li's innovative work in photodynamic therapy represents a significant advancement in cancer treatment. His patented conjugate showcases the potential for targeted therapy, improving patient outcomes in the fight against cancer.